Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8545241rdf:typepubmed:Citationlld:pubmed
pubmed-article:8545241lifeskim:mentionsumls-concept:C0678595lld:lifeskim
pubmed-article:8545241lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:8545241lifeskim:mentionsumls-concept:C0205360lld:lifeskim
pubmed-article:8545241lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8545241lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:8545241lifeskim:mentionsumls-concept:C0086191lld:lifeskim
pubmed-article:8545241pubmed:issue7lld:pubmed
pubmed-article:8545241pubmed:dateCreated1996-2-13lld:pubmed
pubmed-article:8545241pubmed:abstractTextEight analogues of DYN A(1-11)-NH2 incorporating the nonhydrolyzable psi [CH2-NH] peptide bond surrogate were tested for their in vitro enzymatic stability in mouse brain homogenates. Results show that the Leu(5)-Arg6 and to a lesser extent the Arg(7)-Ile8 and Ile(8)-Arg9 peptide bonds are the more susceptible to enzymatic cleavage in the native peptide. (Leu5 psi[CH(2)-NH]Arg6)DYN A(1-11)-NH2 exhibits an almost complete resistance to enzymatic cleavage with a half-life greater than 500 min in brain, compared to 42 min for the standard peptide, DYN A(1-11)-NH2.lld:pubmed
pubmed-article:8545241pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8545241pubmed:languageenglld:pubmed
pubmed-article:8545241pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8545241pubmed:citationSubsetIMlld:pubmed
pubmed-article:8545241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8545241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8545241pubmed:statusMEDLINElld:pubmed
pubmed-article:8545241pubmed:issn0196-9781lld:pubmed
pubmed-article:8545241pubmed:authorpubmed-author:HrubyV JVJlld:pubmed
pubmed-article:8545241pubmed:authorpubmed-author:GillespieT...lld:pubmed
pubmed-article:8545241pubmed:authorpubmed-author:HonRRlld:pubmed
pubmed-article:8545241pubmed:authorpubmed-author:DavisT PTPlld:pubmed
pubmed-article:8545241pubmed:authorpubmed-author:MeyerJ PJPlld:pubmed
pubmed-article:8545241pubmed:issnTypePrintlld:pubmed
pubmed-article:8545241pubmed:volume16lld:pubmed
pubmed-article:8545241pubmed:ownerNLMlld:pubmed
pubmed-article:8545241pubmed:authorsCompleteYlld:pubmed
pubmed-article:8545241pubmed:pagination1215-9lld:pubmed
pubmed-article:8545241pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:meshHeadingpubmed-meshheading:8545241-...lld:pubmed
pubmed-article:8545241pubmed:year1995lld:pubmed
pubmed-article:8545241pubmed:articleTitleIn vitro stability of some reduced peptide bond pseudopeptide analogues of dynorphin A.lld:pubmed
pubmed-article:8545241pubmed:affiliationDepartment of Chemistry, University of Arizona, Tucson 85721, USA.lld:pubmed
pubmed-article:8545241pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8545241pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8545241pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8545241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8545241lld:pubmed